Free Trial

Daxor (DXR) Insider Trading & Ownership

Daxor logo
$8.20 +0.08 (+0.99%)
(As of 12/18/2024 05:26 PM ET)

Daxor (NASDAQ:DXR) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
59.00%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$6,525.00
Number Of
Insiders Selling
(Last 12 Months)
0
Get DXR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Daxor stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

DXR Insider Buying and Selling by Quarter

Daxor Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/27/2024Robert J MichelCFOBuy750$8.70$6,525.00  
(Data available from 1/1/2013 forward)

DXR Insider Trading Activity - Frequently Asked Questions

The list of insiders at Daxor includes Michael Richard Feldschuh, and Robert J Michel. Learn more on insiders at DXR.

59.00% of Daxor stock is owned by insiders. Learn more on DXR's insider holdings.

The following insiders have purchased DXR shares in the last 24 months: Michael Richard Feldschuh ($9,387.85), and Robert J Michel ($16,400.00).

Insiders have purchased a total of 3,131 DXR shares in the last 24 months for a total of $25,787.85 bought.

Daxor Key Executives

  • Mr. Jonathan Adam Feldschuh (Age 59)
    Chief Scientific Officer & Director
    Compensation: $127.92k
  • Mr. Michael Richard Feldschuh (Age 55)
    Chairman, President & CEO
    Compensation: $100k
  • Mr. Robert J. Michel CPA (Age 67)
    CPA, M.B.A., CFO, Chief Compliance Officer & Corporate Secretary
  • Ms. Linda Cooper
    Vice President of Development & Operations
  • Ms. Kathryn A. Kornafel
    Senior VP of Marketing & Commercial Development
  • Mr. Guido Manzo
    Vice President of Sales
  • Ms. Jean Oertel
    Senior Vice President Commercialization & Customer Experience
  • Dr. John Lynn Jefferies FACC
    M.B.A., M.D., M.P.H., Chief Medical Officer


This page (NASDAQ:DXR) was last updated on 12/19/2024 by MarketBeat.com Staff
From Our Partners